CC
AGIO icon

Commodore Capital’s Agios Pharmaceuticals AGIO Stock Holding History

Commodore Capital’s Portfolio AGIO Stock Details AGIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-2,338,287
Closed -$93.9M – 34
2025
Q3 		$93.9M Buy
2,338,287
+13,287
+0.6% +$500K 4.58% 6
2025
Q2 		$77.3M Buy
2,325,000
+140,000
+6% +$4.24M 5.46% 5
2025
Q1 		$64M Buy
+2,185,000
New +$72.5M 4.72% 7

Other funds holding AGIO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $10.8B AUM 38.54% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
NAMI
Nomura Asset Management International Philadelphia, Pennsylvania $58.4B AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BNP Paribas Asset Management
BNP Paribas Asset Management Paris, France $86.1B AUM 29.11% 1-Year Est. Return

Commodore Capital's AGIO Position: Q4 2025 in Review

Commodore Capital sold out of Agios Pharmaceuticals (AGIO) in Q4 2025, closing a stake of 2,338,287 shares — an estimated $93.9M sold.

Commodore Capital first reported a position in AGIO in Q1 2025 and held it in 3 quarters. The position peaked at $93.9M in Q3 2025. 237 funds tracked by Wall St. Rank hold AGIO as of Q4 2025.

  • Commodore Capital reported no remaining Agios Pharmaceuticals position as of Q4 2025 after selling out during the quarter.
  • Commodore Capital sold 2,338,287 Agios Pharmaceuticals shares in Q4 2025, an estimated $93.9M.
  • Commodore Capital first reported a position in Agios Pharmaceuticals in Q1 2025 and held it in 3 quarters.
  • Commodore Capital's Agios Pharmaceuticals position peaked at $93.9M in Q3 2025.
  • 237 funds tracked by Wall St. Rank held Agios Pharmaceuticals as of Q4 2025.

Based on Commodore Capital's 13F filing for Q4 2025, filed 17 Feb 2026.